Carey Oconnor Kolaja serves as Executive at Revance Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Carey Oconnor Kolaja has executed 7 insider transactions totaling $70.6K, demonstrating a bearish approach to their equity position. Their most recent transaction on May 1, 2024 involved receiving (via award) 15,000 shares valued at $0.
Carey Oconnor Kolaja currently holds 31,561 shares of Revance Therapeutics, Inc. (RVNC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Carey Oconnor Kolaja has been a net seller of RVNC stock. They have purchased $0 and sold $70.6K worth of shares.
Carey Oconnor Kolaja's most recent insider trade was on May 1, 2024, when they sold 15,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $18.12 |
| Planned |
| Jun 15, 2023 | RVNC | $70.6K | Sale | 2,500 | $28.24 | Planned |
| May 3, 2023 | RVNC | $0 | Award | 3,534 | $N/A | Discretionary |
| May 4, 2022 | RVNC | $0 | Award | 6,059 | $N/A | Discretionary |
| May 5, 2021 | RVNC | $0 | Award | 674 | $N/A | Discretionary |
| Mar 1, 2021 | RVNC | $0 | Award | 6,294 | $N/A | Discretionary |